SAM
MDCO

Shell Asset Management’s Medicines Co MDCO Stock Holding History

Shell Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,370
Closed -$541K – 1247
2019
Q4 		$541K Sell
6,370
-145
-2% -$9.67K 0.01% 852
2019
Q3 		$326K Buy
+6,515
New +$260K 0.01% 1051

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Shell Asset Management's MDCO Position: Q1 2020 in Review

Shell Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 6,370 shares — an estimated $541K sold.

Shell Asset Management first reported a position in MDCO in Q3 2019 and held it in 2 quarters. The position peaked at $541K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Shell Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Shell Asset Management sold 6,370 Medicines Co shares in Q1 2020, an estimated $541K.
  • Shell Asset Management first reported a position in Medicines Co in Q3 2019 and held it in 2 quarters.
  • Shell Asset Management's Medicines Co position peaked at $541K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Shell Asset Management's 13F filing for Q1 2020, filed 11 May 2020.